Human telomerase reverse transcriptase (TERT) is the catalytic subunit of telomerase, and it elongates telomere through RNA-dependent DNA polymerase activity. Although TERT is named as a reverse transcriptase, structural and phylogenetic analyses of TERT demonstrate that TERT is a member of right-handed polymerases, and relates to viral RNA-dependent RNA polymerases (RdRPs) as well as viral reverse transcriptase. We firstly identified RdRP activity of human TERT that generates complementary RNA stand to a template non-coding RNA and contributes to RNA silencing in cancer cells. To analyze this non-canonical enzymatic activity, we developed RdRP assay with recombinant TERT in 2009, thereafter established in vitro RdRP assay for endogenous TERT. In this manuscript, we describe the latter method. Briefly, TERT immune complexes are isolated from cells, and incubated with template RNA and rNTPs including radioactive rNTP for RdRP reaction. To eliminate single-stranded RNA, reaction products are treated with RNase I, and the final products are analyzed with polyacrylamide gel electrophoresis. Radiolabeled RdRP products can be detected by autoradiography after overnight exposure.
Introduction
Human telomerase reverse transcriptase (TERT) is well known as the catalytic subunit of telomerase, and it elongates telomere using telomerase RNA component (TERC), the specific RNA template 1 . Although TERT polymerizes telomeric DNA as a component of telomerase, the structural and phylogenetic analyses indicate that TERT is closely related with viral RNA-dependent RNA polymerases (RdRPs) as well as viral reverse transcriptase, and shares domains with these polymerases 2, 3, 4 . RdRP is the enzyme that generates complementary RNA strand to a template RNA. The enzyme is encoded not only in viruses but also in model organisms, such as plant, yeast and worm, and double-stranded RNA synthesis by RdRP contributes to transcriptional and post-transcriptional gene silencing in these organisms 5, 6 . Although human RdRP had been missing for a long time, we found RdRP activity in human TERT in 2009 7 .
We first confirmed RdRP activity of TERT with recombinant protein 7 , then established a sensitive in vitro assay to detect RdRP activity of endogenous TERT 8 . Here, we demonstrate the in vitro RdRP assay (IP-RdRP assay) for endogenous TERT. This method starts with immunoprecipitation (IP) of endogenous TERT, and is followed by in vitro RdRP reaction, in which radioactive ribonucleotides are incorporated into nascent RNA strands.
1. Pre-clear the lysate from step 3.2.6 by adding 40 µL (bead volume 20 µL) of prewashed protein A-agarose beads per 1 mL of the lysate. Mix well by inverting the tube several times and rotate the sample for 30 min at 4 °C. 2. Centrifuge the sample at 13,000 x g for 1 min at 4 °C, and recover the supernatant. 3. Add 40 µL (bed volume 20 µL) of prewashed protein A-agarose beads and 10 µg of anti-human TERT antibody (clone: 10E9-2) 8 into the pre-cleared lysate. Mix well by inverting the tube several times and rotate the sample at 4 °C over night. 4. Centrifuge the sample at 3,300 x g for 0.5 min at 4 °C, and remove the supernatant. 5. Wash the beads with Wash buffer 1: add 1 mL of Wash buffer 1 to the beads, mix well by inverting the tube, and rotate the sample for 5 min at 4 °C. Centrifuge the sample at 3,300 x g for 0.5 min at 4 °C, and remove the supernatant. Repeat this step three additional times. 6. Wash the beads once with AGC solution containing 2 mM CaCl 2 : add 1 mL of AGC solution containing 2 mM CaCl 2 to the beads, mix well by inverting the tube, and rotate the sample for 5 min at 4 °C. Centrifuge the sample at 3,300 x g for 0.5 min at 4 °C, and remove the supernatant. 7. Treat the beads with Micrococcal nuclease (MNase): prepare the MNase reaction mixture described in Table 1 . Resuspend the beads in 60 µL of the MNase reaction mixture by gentle pipetting. Shake the sample gently (20 to 25 rpm) on a turntable of a shaker set in a Peltier-type incubator for 15 min at 25 °C. NOTE: It is very important to use an undulating shaker and strictly follow the speed limit in this step. Other type of shakers, such as rotating mixers, are not recommended. 8. Centrifuge the sample at 3,300 x g for 0.5 min at 4 °C, and remove the supernatant. In case that there is only a ~30 nt product with weak signal in mitotic HeLa cells, it indicates that the RdRP reaction did not go well. For example, if MNase treatment is performed roughly and inappropriately, the signal intensity in mitotic HeLa cells decreases significantly ( Figure 1B) . RdRP reaction performed with old HMD solution also reduces the products (Figure 1C ). 
Reagents Volume
Micrococcal Nuclease, 20 U/µL 1 µL
Micrococcal Nuclease Buffer, 10x 8 µL
RNase-free water 51 µL 
